ClinicalTrials.Veeva
Menu

Find clinical trials for Endometrial Cancer in Seattle, WA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Carcinoma
Cancer
Ovarian Cancer
Breast Cancer
Ovarian Epithelial Carcinoma
Triple Negative Breast Cancer
Lung Cancer

Endometrial Cancer trials near Seattle, WA, USA:

Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer

A Phase 2 Multi-center Open-label Trial of nab-Sirolimus in Combination with Letrozole in Advanced or Recurrent Endometrioid Endometrial Cancer...

Enrolling
Endometrial Cancer
Endometrioid Endometrial Cancer
Drug: nab-sirolimus

Phase 2

Aadi Bioscience

Seattle, Washington, United States and 8 other locations

(paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial...

Active, not recruiting
Endometrial Neoplasms
Drug: Carboplatin
Biological: durvalumab

Phase 3

AstraZeneca
AstraZeneca

Seattle, Washington, United States and 202 other locations

participants with recurrent or primary advanced (Stage III or IV) endometrial cancer....

Active, not recruiting
Neoplasms
Drug: Carboplatin
Drug: Paclitaxel

Phase 3

Tesaro
Tesaro

Seattle, Washington, United States and 162 other locations

drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in participants with advanced or metastatic breast cancer...

Active, not recruiting
Endometrial Cancer
Breast Cancer
Drug: Trastuzumab
Drug: Everolimus

Phase 1

Lilly
Lilly

Seattle, Washington, United States and 72 other locations

Phase 1, first-in-human, open label study of CAR macrophages in HER2 overexpressing solid tumors.

Active, not recruiting
Lung Cancer, Non-Small-Cell
HER2-positive Breast Cancer
Biological: CT-0508
Biological: Pembrolizumab

Phase 1

Carisma Therapeutics

Seattle, Washington, United States and 6 other locations

to other places in the body, it is called advanced or metastatic cancer. Participants in this study must have head and neck squamous cell ca ...

Enrolling
Endometrial Neoplasms
Ovarian Neoplasms
Drug: disitamab vedotin

Phase 2

Seagen
Seagen

Seattle, Washington, United States and 30 other locations

in participants with platinum-resistant ovarian carcinoma, endometrial adenocarcinoma, and urothelial carcinoma based on Acrivon's OncoSigna...

Enrolling
Endometrial Adenocarcinoma
Platinum-resistant Ovarian Cancer
Drug: ACR-368
Diagnostic Test: OncoSignature

Phase 1, Phase 2

Acrivon Therapeutics

Seattle, Washington, United States and 67 other locations

The purpose of this study is to further evaluate the efficacy and safety of niraparib in patients with locally advanced or metastatic solid tumors an...

Active, not recruiting
Esophageal Cancer
Urologic Cancer
Drug: Niraparib

Phase 2

Tempus AI
Tempus AI

Tacoma, Washington, United States and 79 other locations

First-in-human, open-label, sequential dose escalation and expansion study of CPI-0209 in patients with advanced solid tumors and lymphomas. CPI-0209...

Enrolling
Endometrial Cancer
Lymphoma, T-Cell
Drug: CPI-0209

Phase 1, Phase 2

Constellation Pharmaceuticals

Seattle, Washington, United States and 49 other locations

that can be given to participants with ovarian cancer or cancer of the uterus* Look for signs that the study drugs can treat ovari...

Enrolling
Endometrial Cancer
Primary Peritoneal Cancer
Drug: Sarilumab
Drug: REGN4018

Phase 1, Phase 2

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Seattle, Washington, United States and 10 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems